Adhesive substrate-modulation of adaptive immune responses.

While it is well-known that adsorbed proteins on implanted biomaterials modulate inflammatory responses, modulation of dendritic cells (DCs) via adhesion-dependent signaling has only been begun to be characterized. In this work, we demonstrate that adhesive substrates elicit differential DC maturation and adaptive immune responses. We find that adhesive substrates support similar levels of DC adhesion and expression of stimulatory and co-stimulatory molecules. Conversely, DC morphology and differential production of pro- and anti-inflammatory cytokines (IL-12p40 and IL-10, respectively) is adhesive substrate-dependent. For example, DCs cultured on collagen and vitronectin substrates generate higher levels of IL-12p40, whereas DCs cultured on albumin and serum-coated tissue culture-treated substrates produce the higher levels of IL-10 compared to other substrates. Additionally, our results suggest substrate-dependent trends in DC-mediated allogeneic CD4(+) T-cell proliferation and T-helper cell type responses. Specifically, we show that substrate-dependent modulation of DC IL-12p40 cytokine production correlates with CD4(+) T-cell proliferation and T(h)1 type response in terms of IFN-gamma producing T-helper cells. Furthermore, our results suggest substrate-dependent trends in DC-mediated stimulation of IL-4 producing T-cells, but this T(h)2 type response is not dependent on DC production of IL-10 cytokine. This work has impact in the rational design of biomaterials for diverse applications such as tissue-engineered constructs, synthetic particle-based vaccines and the ex vivo culture of DCs for immunotherapies.

[1]  G. Schuler,et al.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.

[2]  R. Pauwels,et al.  Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. , 1998, Journal of immunology.

[3]  S. Gambhir,et al.  Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. , 2008, Clinical immunology.

[4]  P. Brossart,et al.  Cellular Immunotherapy with Dendritic Cells in Cancer: Current Status , 2004, Stem cells.

[5]  C. Johansson,et al.  Phenotype and function of intestinal dendritic cells. , 2005, Seminars in immunology.

[6]  J. Babensee,et al.  Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. , 2006, Journal of biomedical materials research. Part A.

[7]  G. Maestroni,et al.  Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. , 2003, Journal of neuroimmunology.

[8]  James E. Evans,et al.  Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.

[9]  S. Ju,et al.  A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. , 2006, Journal of immunology.

[10]  T. Bieber,et al.  Subpopulations of human dendritic cells display a distinct phenotype and bind differentially to proteins of the extracellular matrix. , 2007, European journal of cell biology.

[11]  Y. Bobryshev,et al.  Clustering of dendritic cells in athero-prone areas of the aorta. , 1999, Atherosclerosis.

[12]  J M Anderson,et al.  Adsorbed serum proteins responsible for surface dependent human macrophage behavior. , 2000, Journal of biomedical materials research.

[13]  Benjamin G Keselowsky,et al.  Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries. , 2005, Biomaterials.

[14]  C. Janeway,et al.  Innate immune recognition and control of adaptive immune responses. , 1998, Seminars in immunology.

[15]  Sai T Reddy,et al.  Targeting dendritic cells with biomaterials: developing the next generation of vaccines. , 2006, Trends in immunology.

[16]  G. Rosati,et al.  Glatiramer acetate reduces lymphocyte proliferation and enhances IL‐5 and IL‐13 production through modulation of monocyte‐derived dendritic cells in multiple sclerosis , 2006, Clinical and experimental immunology.

[17]  R. Steinman,et al.  Dendritic Cells: Features and Functions , 1980, Immunological reviews.

[18]  J. Banchereau,et al.  Human Dendritic Cells Skew Isotype Switching of CD40-activated Naive B Cells towards IgA1 and IgA2 , 1997, The Journal of experimental medicine.

[19]  R. Dutton FURTHER STUDIES OF THE STIMULATION OF DNA SYNTHESIS IN CULTURES OF SPLEEN CELL SUSPENSIONS BY HOMOLOGOUS CELLS IN INBRED STRAINS OF MICE AND RATS , 1965, The Journal of experimental medicine.

[20]  H. Waldmann,et al.  Induction of Regulatory T Cells and Dominant Tolerance by Dendritic Cells Incapable of Full Activation1 , 2007, The Journal of Immunology.

[21]  Polly Matzinger,et al.  Friendly and dangerous signals: is the tissue in control? , 2007, Nature Immunology.

[22]  J. Babensee Interaction of dendritic cells with biomaterials. , 2008, Seminars in immunology.

[23]  O. Majdic,et al.  Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. , 2000, Blood.

[24]  A. Enk,et al.  Influence of extracellular matrix proteins on the development of cultured human dendritic cells , 1998, European journal of immunology.

[25]  S. Hamdy,et al.  “Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells , 2007, Journal of immunotherapy.

[26]  Franco Patrone,et al.  The use of dendritic cells in cancer immunotherapy. , 2008, Critical reviews in oncology/hematology.

[27]  S. Ranjit,et al.  Potential role of dendritic cells for progression of atherosclerotic lesions , 2006, Postgraduate Medical Journal.

[28]  S. Ju,et al.  A Major Lung CD103 (αE)-β7 Integrin-Positive Epithelial Dendritic Cell Population Expressing Langerin and Tight Junction Proteins1 , 2006, The Journal of Immunology.

[29]  Hiroshi Nakajima,et al.  Role of Cytokines in Allergic Airway Inflammation , 2006, International Archives of Allergy and Immunology.

[30]  Benjamin G Keselowsky,et al.  Role of plasma fibronectin in the foreign body response to biomaterials. , 2007, Biomaterials.

[31]  M. Schwarz,et al.  THE MIXED LYMPHOCYTE REACTION: AN IN VITRO TEST FOR TOLERANCE , 1968, The Journal of experimental medicine.

[32]  Benjamin G. Keselowsky,et al.  Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Y. Sung,et al.  IL-12 Provides Proliferation and Survival Signals to Murine CD4+ T Cells Through Phosphatidylinositol 3-Kinase/Akt Signaling Pathway1 , 2002, The Journal of Immunology.

[34]  H. Hammad,et al.  Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma , 2008, Nature Reviews Immunology.

[35]  M. Clare-Salzler,et al.  Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. , 2006, Autoimmunity reviews.

[36]  J. Babensee,et al.  Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering. , 2004, Biomaterials.

[37]  Andrés J. García,et al.  Specific β1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum , 2004, Molecular and Cellular Neuroscience.

[38]  P. Ricciardi-Castagnoli,et al.  Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo , 1999, Nature Medicine.

[39]  T. Horio,et al.  Ultraviolet B radiation suppresses Langerhans cell migration in the dermis by down‐regulation of α4 integrin , 2006, Photodermatology, photoimmunology & photomedicine.

[40]  P. Matzinger,et al.  An innate sense of danger. , 1998, Seminars in immunology.

[41]  M. Clare-Salzler,et al.  Dexamethasone Induces IL‐10‐Producing Monocyte‐Derived Dendritic Cells with Durable Immaturity , 2005, Scandinavian journal of immunology.

[42]  Sai T Reddy,et al.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.

[43]  M. Shen,et al.  The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. , 2001, Journal of biomedical materials research.

[44]  T. Starzl,et al.  Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony- stimulating factor , 1995, The Journal of experimental medicine.

[45]  W. Saltzman,et al.  Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells. , 2007, Molecular pharmaceutics.

[46]  Benjamin G Keselowsky,et al.  Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. , 2004, Biomaterials.

[47]  N. Longo,et al.  Maturation-Dependent Expression and Function of the CD49d Integrin on Monocyte-Derived Human Dendritic Cells1 , 2000, The Journal of Immunology.

[48]  Benjamin G Keselowsky,et al.  Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. , 2003, Journal of biomedical materials research. Part A.

[49]  Benjamin G Keselowsky,et al.  Quantitative methods for analysis of integrin binding and focal adhesion formation on biomaterial surfaces. , 2005, Biomaterials.

[50]  Jingwei Xu,et al.  Role of dendritic cells and chemokines in acute graft-versus-host disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[51]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[52]  Wolfgang Weninger,et al.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells , 2003, Nature.

[53]  M. Ågren,et al.  The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds , 2007, The international journal of lower extremity wounds.

[54]  山口 剛史 Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction , 2008 .

[55]  J. Vörös,et al.  Improved Stimulation of Human Dendritic Cells by Receptor Engagement with Surface-modified Microparticles , 2003, Journal of drug targeting.

[56]  Balancing life and death , 2004, Nature Immunology.

[57]  M. Macey,et al.  Human blood dendritic cells: binding to vascular endothelium and expression of adhesion molecules , 1997, Clinical and experimental immunology.

[58]  R. Dutton SPLEEN CELL PROLIFERATION IN RESPONSE TO HOMOLOGOUS ANTIGENS STUDIED IN CONGENIC RESISTANT STRAINS OF MICE , 1966, The Journal of experimental medicine.

[59]  J W Eaton,et al.  Fibrin(ogen) mediates acute inflammatory responses to biomaterials , 1993, The Journal of experimental medicine.

[60]  M. Croft,et al.  Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. , 1995, Journal of immunology.

[61]  M. Schwarz THE MIXED LYMPHOCYTE REACTION: AN IN VITRO TEST FOR TOLERANCE*, , 1968 .

[62]  L. Schwarzfischer,et al.  Comparative analysis of integrin expression on monocyte‐derived macrophages and monocyte‐derived dendritic cells , 2000, Immunology.

[63]  T. Oliver,et al.  Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin , 2006, The EMBO journal.

[64]  R. Grencis,et al.  Induction of Enhanced Immunity to Intestinal Nematodes Using IL-9-Producing Dendritic Cells1 , 2006, The Journal of Immunology.

[65]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[66]  J. Benda,et al.  Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances. , 1999, ASAIO journal.

[67]  J. Dalgaard,et al.  Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets , 2005, Journal of leukocyte biology.

[68]  B. Boyan,et al.  Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. , 2007, Journal of biomedical materials research. Part A.

[69]  H. Link,et al.  Tolerogenic dendritic cells: the ins and outs of outcome. , 2006, Journal of immunotherapy.

[70]  M. Roth,et al.  Adenoviral‐encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of αvβ3 integrins , 2006 .